Israel
Glucose Monitoring Devices Market is expected to grow at an impressive rate during
the forecast period. The country is witnessing a growing demand for glucose
monitoring devices due to the increasing prevalence of diabetes. Advancements
in technologies, rising healthcare expenditure, and growing awareness about
diabetes are also supporting the Israel glucose monitoring devices market.
The
market is witnessing significant technological advancements. New devices are
being developed that are more accurate, reliable, and user-friendly. For
example, continuous glucose monitoring (CGM) devices are becoming increasingly
popular in Israel, as they provide real-time glucose readings and allow people
to monitor their glucose levels continuously.
There
is a growing awareness about diabetes in Israel, which is leading to an
increase in the demand for glucose monitoring devices. People are becoming more
aware of the importance of monitoring their blood glucose levels regularly and
are taking proactive steps to manage their condition effectively.
While
the glucose monitoring devices market in Israel is growing, several factors may
hamper its growth in the coming years. These factors include limited healthcare
infrastructure, high cost of devices, lack of awareness about effective
management of diabetes, limited reimbursement policies, and limited
availability of devices. The cost of glucose monitoring devices can be high,
especially for advanced devices, such as continuous glucose monitoring (CGM)
systems. This high cost can limit the market’s growth, as people may not be
able to afford the devices, especially those with limited financial resources.
While
there is growing awareness about diabetes in Israel, many people still lack
adequate knowledge about the condition and how to manage it effectively. This
lack of awareness can also limit the market's growth, as people may not see the
need to monitor their blood glucose levels regularly or may not understand the
benefits of using glucose monitoring devices.
The
geriatric population in Israel is continuously rising, and older adults are at
a higher risk of developing diabetes. This growing population is expected to
drive the demand for glucose monitoring devices in the coming years, as older
adults need to monitor their blood glucose levels regularly to manage their
condition effectively.
Mobile
applications are becoming increasingly popular in the glucose monitoring
devices market. These applications can help people with diabetes track their
blood glucose levels, record insulin doses, and monitor other health metrics.
Mobile applications are user-friendly, easy to access, and can provide
real-time information to people with diabetes, which is expected to drive their
demand in the coming years.
Artificial
Intelligence (AI) is also playing a significant role in the growth of the
glucose monitoring devices market in Israel. AI algorithms can analyze glucose
data and provide personalized insights to people with diabetes. These insights
can help people with diabetes manage their condition more effectively and
prevent complications. AI-powered glucose monitoring devices are expected to
become increasingly popular in Israel in the coming years.
Wearable
devices are another technological advancement that is driving the glucose
monitoring devices market in Israel. These devices can be worn on the body and
can provide real-time glucose readings, similar to CGM systems. Wearable
devices are user-friendly, easy to access, and can provide people with diabetes
with more flexibility in monitoring their blood glucose levels.
Increasing
Prevalence of Diabetes
The
prevalence of diabetes in Israel is one of the primary factors driving the
growth of this market. One of the top ten primary causes of death worldwide is
diabetes mellitus (DM). Diabetes mellitus is becoming more prevalent, which has
a significant negative impact on both financial and physical well-being. According
to the WHO, published in 2020, Israel touched 1913 deaths by Diabetes Mellitus,
which is 5.44% of total deaths in the country. Diabetes mellitus (DM) is
characterized as a chronic condition of carbohydrate metabolism brought on by
inadequate or unresponsive insulin secretion. Type 1 DM, type 2 DM (which is
the most prevalent), and gestational DM are the three main forms. Micro- and
macrovascular consequences from long-term untreated DM can increase morbidity
and mortality in diabetics.
The
prevalence of diabetes in Israel is expected to continue to increase in the
coming years due to several factors, including lifestyle changes, urbanization,
and an aging population. As the number of people living with diabetes in Israel
increases, so does the demand for glucose-monitoring devices. Glucose
monitoring devices are essential for people with diabetes to manage their
condition effectively. They allow people with diabetes to monitor their blood
glucose levels regularly and adjust their treatment plan accordingly. Without
regular monitoring, people with diabetes are at risk of developing
complications, such as blindness, kidney failure, and cardiovascular diseases.
Download Free Sample Report
Growing
Awareness Regarding Diabetes Mellitus
Growing
awareness regarding diabetes mellitus is driving the glucose monitoring devices
market in Israel in the coming years. There are several education and awareness
campaigns aimed at informing people about diabetes mellitus and its management.
These campaigns are designed to educate people on the importance of blood
glucose monitoring, healthy lifestyle changes, and the use of glucose
monitoring devices in managing diabetes. These awareness campaigns are driving
demand for glucose monitoring devices in Israel, as more people are becoming
aware of the importance of using these devices to manage their diabetes.
Healthcare
professionals play a vital role in raising awareness of diabetes mellitus and
glucose monitoring devices in Israel. Doctors, nurses, and other healthcare
professionals are recommending glucose monitoring devices to their patients to
help them manage their diabetes effectively. This is driving demand for glucose
monitoring devices in Israel, as more people are following their healthcare
professional's advice and using these devices.
Technological
Advancements
There
have been several technological advancements in glucose monitoring devices in Israel
in recent years. One of the most significant advances is the introduction of
continuous glucose monitoring (CGM) devices, which allow for continuous and
automatic tracking of blood glucose levels. These devices have proven to be
particularly useful for people with type 1 diabetes, as they can help prevent
severe hypoglycemia and hyperglycemia by alerting users to changes in their
glucose levels in real time. Another advancement is the development of
non-invasive glucose monitoring devices, which use infrared light or ultrasound
to measure glucose levels without the need for a fingerstick. These devices are
particularly useful for people who are uncomfortable with the traditional
fingerstick method or have difficulty performing it themselves. Additionally, mobile
applications have been developed that allow for remote monitoring of glucose
levels, enabling healthcare professionals and caregivers to keep track of
patients' glucose levels in real-time. These technological advancements have
made it easier and more convenient for people to monitor their blood glucose
levels and manage their diabetes effectively.
Market Segmentation
The
Israel glucose monitoring devices market can be segmented by product, application,
end user, and region. By product, the market can be
segmented into self-monitoring glucose devices and continuous glucose
monitoring devices. Based on application, the market is divided into Type 1
Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on end user, the
market is divided into home care settings, hospital, and others.
Market Players
Roche Israel, Abbott
Diagnostics, MEDTRONIC ISRAEL LLC., Johnson & Johnson, LifeScan Israel, and
Ascensia Diabetes Care are some of the leading companies operating in the
market.
Attribute
|
Details
|
Base Year
|
2022
|
Historic Data
|
2018 – 2022
|
Estimated Year
|
2023
|
Forecast Period
|
2024 – 2028
|
Quantitative Units
|
Revenue in USD Million, Volume Units, and
CAGR for 2018-2022 and 2023-2028
|
Report Coverage
|
Revenue forecast, Volume forecast company share, competitive
landscape, growth factors, and trends
|
Segments Covered
|
Product
Application
End User
|
Regional Scope
|
The Mediterranean Coastal Plain, The Central Hills, The Jordan
Rift Valley, The Negev Desert.
|
Key Companies Profiled
|
Roche Israel, Abbott Diagnostics, MEDTRONIC ISRAEL LLC.,
Johnson & Johnson, LifeScan Israel, Ascensia Diabetes Care
|
Customization Scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
Pricing and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report
Scope:
In this
report, the Israel glucose monitoring devices market has been segmented into the
following categories, in addition to the industry trends which have also been
detailed below:
- Israel
Glucose Monitoring Devices Market, By Product
- Self-Monitoring Glucose
Devices
- Continuous Glucose
Monitoring Devices
- Israel Glucose Monitoring
Devices Market, By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Israel Glucose Monitoring Devices
Market, By End User
- Home Care Settings
- Hospital
- Others
Competitive
Landscape
Company Profiles: Detailed analysis of the major companies
present in the Israel glucose monitoring devices market.
Available
Customizations:
With the
given market data, TechSci Research offers customizations according to a
company’s specific needs. The following customization options are available for
the report:
Company
Information
- Detailed analysis and
profiling of additional market players (up to five).
Israel
Glucose Monitoring Devices Market is an upcoming report to be released soon. If you
wish an early delivery of this report or want to confirm the date of release,
please contact us at [email protected]